Notably, at day 7, the PCL/AZ-CS/dECM/NAC group showed a trend toward superior performance with a remaining area of 29.060 ± 2.921%, compared to 42.737 ± 3.119% for the PCL/AZ-CS/dECM group.
← all excerpts
A Biomimetic NAC-Loaded PCL/Modified Chitosan/dECM Fibrous Scaffold for Accelerating Diabetic Wound Healing and Minimizing Scarring.
1
—
—